🍂 Enjoy the Fall Season! 🍂
MindTheDesk

Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial

Business Archived • September 30, 2026 • 3 views
Lilly said it plans to start Phase 3 trials on the combo regimen adding its amylin drug eloralintide to tirzepatide at the end of the year. 
Source: CNBC Top | https://search.cnbc.com/rs/search/combinedcms/view.xml?partnerId=wrss01&id=100003114 - Read Original
"Get your business promoted today."
"Monetize your website or boost your business with Code-Oryx. Join the network today!"

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored
"Network Cable Repairs from $29"
"House Plans for Structures New and Old"